Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta®
Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta®…
News
Vectra AI Introduces the Industry’s First AI-Driven, Fully Integrated Hybrid Attack Detection and Response Platform with Real-Time Attack Signal Intelligence
Vectra AI Platform arms security operations centers (SOC) with the integrated signal to deliver extended…
Oilfield Injury Lawyer Services for Odessa Workers Announced by Reyna Law Firm
Odessa, Texas–(Newsfile Corp. – August 8, 2023) – Reyna Law Firm has brought forward new…
Fujitsu to provide Cargotec with global workplace and infrastructure IT services enhancing user experience and increasing productivity
TOKYO, Aug 8, 2023 – (JCN Newswire) – Fujitsu today announced that it will start…
Unlock the Power of Targeted Traffic with Simple Traffic, the Revolutionary Visitor-Forwarding Platform that Redirects Quality Traffic to Client Websites
Tallinn, Estonia–(Newsfile Corp. – August 7, 2023) – Simple Traffic, a leading-edge targeted traffic generation…
Matsuyama Mikan Energy selects Hitachi’s grid energy storage system with e-mesh PowerStore
TOKYO, Aug 8, 2023 – (JCN Newswire) – Hitachi, Ltd. (TSE: 6501) has received an…
Sixth Street Specialty Lending, Inc. Prices Public Offering of $300.0 million 6.950% Unsecured Notes due 2028
NEW YORK–(BUSINESS WIRE)–Sixth Street Specialty Lending, Inc. (NYSE:TSLX) (“TSLX” or the “Company”) announced today that…
From AI Chatbots to CPO: How Communications Technology Helps the World to Change
HONG KONG, Aug 8, 2023 – (ACN Newswire) – In February 2023, ChatGPT, OpenAI’s text-generating…
First Edition of Saudi Film Confex Set to Debut in Riyadh
RIYADH, Aug 8, 2023 – (ACN Newswire) – The Saudi Film Commission is expected to…
ACELYRIN, INC. to Present Second Quarter 2023 Financial Results and Corporate Update on August 14, 2023
LOS ANGELES, Aug. 07, 2023 (GLOBE NEWSWIRE) — ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical…
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
Results from FIREFLY-1 demonstrate overall response rate (ORR) of 67% and clinical benefit rate (CBR)…
Cellectis Provides Full Report for Second Quarter 2023 Financial Results
NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (the “Company”) (Euronext Growth: ALCLS-…
AnaptysBio Announces Second Quarter 2023 Financial Results and Provides Business Update
Completed enrollment of the GEMINI-1 Phase 3 trial for imsidolimab (IL-36R) in generalized pustular psoriasis (GPP)…
Bolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
First patients dosed in the BDC-1001 Phase 2 program BDC-1001 Phase 1 data presented at…
Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
Q2 2023 revenue $23.5 million, 31% y/y growth Reiterating FY 2023 revenue guidance range of…
QIAGEN receives FDA approval for companion diagnostic to Blueprint Medicines’ AYVAKIT® (avapritinib) in gastrointestinal stromal tumors
QIAGEN’s therascreen PDGFRA RGQ PCR kit approved in U.S. to aid in identifying patients with…
Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status
SALT LAKE CITY, Aug. 07, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN), a leader…
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
Company plans to initiate a Phase 2 SEISMiC extension study of istaroxime in early cardiogenic…
Mineralys Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
– Continue enrolling subjects in ongoing pivotal Advance-HTN trial of lorundrostat, for the treatment of…
T2 Biosystems Announces Second Quarter 2023 Financial Results
Received FDA Breakthrough Device Designation for Candida auris test, achieved record quarterly sepsis test panel…